“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

In drug development, the active pharmaceutical ingredient (API) is the drug component that provides the health benefits. The purpose of adding APIs is to cause pharmacological activity or direct ...

Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing organizations (CDMOs) that claim to have potent ...

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

Watch for the production of active pharmaceutical ingredients (API) to migrate from China and India as Russia, Ukraine and the Baltics ramp up their pharma manufacturing capabilities. Market analyst ...

The shadow technology problem is getting worse.  Over the past few years, organizations have scaled microservices, ...